HIV-1–specific CD4(+) T lymphocyte turnover and activation increase upon viral rebound
HIV-specific CD4(+) T helper lymphocytes are preferred targets for infection. Although complete interruption of combination antiretroviral therapy (ART) can form part of therapeutic manipulations, there is grave concern that the resumption of viral replication might destroy, perhaps irreversibly, th...
保存先:
| 出版年: | J Clin Invest |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Clinical Investigation
2005
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC544605/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15668739/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI23084 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
